Composition:

Each Empacoza 10mg tablet contains: empagliflozin................................................ 10 mg.

Each Empacoza 25mg tablet contains: empagliflozin................................................ 25 mg.

Therapeutic Indications:

• Type 2 Diabetes Mellitus
• Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes
• Also indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and cardiovascular disease
• Indicated to reduce the risk of cardiovascular death plus hospitalization in adults with heart failure (HF).

●     Packaging:

Empacoza 10mg Tablets: Box containing 3 blisters of 10 tablets each.

Empacoza 25mg Tablets: Box containing 3 blisters of 10 tablets each.